GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CRH Medical Corp (AMEX:CRHM) » Definitions » Operating Income

CRH Medical (CRH Medical) Operating Income : $-6.8 Mil (TTM As of Dec. 2020)


View and export this data going back to 2008. Start your Free Trial

What is CRH Medical Operating Income?

CRH Medical's Operating Income for the three months ended in Dec. 2020 was $3.8 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2020 was $-6.8 Mil.

Warning Sign:

CRH Medical Corp has recorded a loss in operating income at least once over the past 3 years.

Operating Margin % is calculated as Operating Income divided by its Revenue. CRH Medical's Operating Income for the three months ended in Dec. 2020 was $3.8 Mil. CRH Medical's Revenue for the three months ended in Dec. 2020 was $36.8 Mil. Therefore, CRH Medical's Operating Margin % for the quarter that ended in Dec. 2020 was 10.35%.

CRH Medical's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. CRH Medical's annualized ROC % for the quarter that ended in Dec. 2020 was 6.02%. CRH Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2020 was -717.41%.


CRH Medical Operating Income Historical Data

The historical data trend for CRH Medical's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CRH Medical Operating Income Chart

CRH Medical Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.77 20.82 20.30 14.68 -6.76

CRH Medical Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.56 -2.60 -8.05 0.09 3.81

CRH Medical Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Dec. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CRH Medical  (AMEX:CRHM) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

CRH Medical's annualized ROC % for the quarter that ended in Dec. 2020 is calculated as:

ROC % (Q: Dec. 2020 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2020 ) + Invested Capital (Q: Dec. 2020 ))/ count )
=15.224 * ( 1 - 25.23% )/( (199.907 + 178.205)/ 2 )
=11.3829848/189.056
=6.02 %

where

Note: The Operating Income data used here is four times the quarterly (Dec. 2020) data.

2. Joel Greenblatt's definition of Return on Capital:

CRH Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2020 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2020 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2020  Q: Dec. 2020
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-92.772/( ( (1.297 + max(10.333, 0)) + (1.192 + max(13.041, 0)) )/ 2 )
=-92.772/( ( 11.63 + 14.233 )/ 2 )
=-92.772/12.9315
=-717.41 %

where Working Capital is:

Working Capital(Q: Sep. 2020 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(20.325 + 0.296 + 0.427) - (9.241 + 0 + 1.474)
=10.333

Working Capital(Q: Dec. 2020 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(23.265 + 0.262 + 0.871) - (9.66 + 0 + 1.697)
=13.041

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2020) EBIT data.

3. Operating Income is also linked to Operating Margin %:

CRH Medical's Operating Margin % for the quarter that ended in Dec. 2020 is calculated as:

Operating Margin %=Operating Income (Q: Dec. 2020 )/Revenue (Q: Dec. 2020 )
=3.806/36.783
=10.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


CRH Medical Operating Income Related Terms

Thank you for viewing the detailed overview of CRH Medical's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


CRH Medical (CRH Medical) Business Description

Traded in Other Exchanges
N/A
Address
999 Canada Place, Suite 578, World Trade Center, Vancouver, BC, CAN, V6C 3E1
CRH Medical Corp is a healthcare products and services company. The company, through its subsidiaries, provides anesthesiology services to gastroenterologists in the United States. It also specializes in the treatment of hemorrhoids utilizing its treatment protocol and patented proprietary technology. The company's product, the CRH O'Regan System, is a single-use, disposable, hemorrhoid treatment. It distributes the CRH O'Regan System, treatment protocols, operational and marketing services directly to gastroenterologists. Geographically, the company operates in the United States and Canada, of which key revenue is derived from the United States.
Executives
Richard Bear officer: Chief Financial Officer 9062 NE 37TH PLACE, BELLEVUE WA 98004
Ian Webb director 7385 LABURNUM ST VANCOUVER A1 V6P 5N2
James Kreger officer: President 2580 ACORN AVE NE ATLANTA GA 30305
Tushar M Ramani director, officer: Chief Executive Officer 118 TALAVERA PLACE PALM BEACH GARDENS FL 33418
Brian T Griffin director
Todd Patrick director 9029 NE 36TH STREET, BELLEVUE WA 98004
David Allan Johnson director 7464 NORTH SHORE ROAD NORFOLK VA 23505
Anthony F Holler director 8855 NORTHBROOK CT BURNABY A1
Edward Wright officer: Chief Financial Officer 2992 WEST 31ST AVE VANCOUVER A1 V6L 2A4